MediciNova Inc. (MNOV) announced after the close Tuesday the presentation of preliminary results from a Phase 1b study of MN-166 in methamphetamine addiction at the 75th Annual Meeting of the College on Problems of Drug Dependence in San Diego.
MediciNova spiked to the upside at the open Wednesday and is now higher by 0.93 at $3.50 on above average volume. The stock has surged to a 1-month high.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.